CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery

Positive
AI Analysis

Summary

Aureka Biotechnologies closed a US$100 million Series B financing round led by Granite Asia and a strategic investor to advance its biological world model for drug discovery platform.

Importance:6/10
Sentiment:
0.70
Series B financingdrug discoverycapital raise
Related Companies

Read the original article

Published by PR Newswire Pharma on August 11, 2026 1:30 AM

Read Original